# Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)

> **NCT02290977** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Portal Vein Tumor Thrombosis

## Interventions

- **RADIATION:** Scheduled interval TACE - RT

## Key facts

- **NCT ID:** NCT02290977
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2015-10
- **Final completion:** 2016-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02290977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02290977, "Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02290977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*